Tags : Wren Capital

BioTech

Adapttech secures £2 million Seed Follow On investment from investors

ADAPTTECH SECURES £2 MILLION IN NEW FUNDING Biomedical company will use funding to develop new technologies and grow sales of next generation system for improving the fitting of prosthetic devices. BIRMINGHAM, UK – MARCH 23, 2021 – Biomedical startup Adapttech announced today that it has raised £2 million in a new venture capital funding round. The round was […]Read More

Wales

Antiverse secures £1.4 million Seed investment from investors including Development

Antiverse raises £1.4 million ($2 million USD) to advance its AI antibody drug discovery platform ·         Funding will accelerate development of the Company’s AI-powered antibody drug discovery technology, focused on identifying new therapeutics for cancer, heart, and lung diseases ·         Technology aims to speed up drug development from years to weeks ·         New laboratory to be built in […]Read More

IndustrialTech

Spotta secures £934k Seed funding led by Cambridge Angels and

FUNDING THE FUTURE OF PEST CONTROL Spotta’s smart pest systems attracts $1.18 million in seed funding EMBARGOED UNTIL 28 JULY 2020, 6AM BST: Investors have rewarded the commercial success of Spotta’s smart pest systems with a $1.18 million seed funding round.  This investment reflects Spotta’s huge potential in global markets in farming, forestry, hospitality, and […]Read More

East of England

PharmEnable secures £1.8 million Seed investment led by Cambridge Enterprise

Cambridge Spin-out PharmEnable Raises £1.8 million for Drug Discovery Expansion £1.8m seed financing led by Cambridge Enterprise alongside angel investors and life science investment funds Using advanced medicinal chemistry and AI approaches to develop highly complex and specific drug candidate molecules Will enable in-house drug discovery across a number of therapeutic areas including cancer and […]Read More